Mendes, R. E., Farrell, D. J., Sader, H. S., Flamm, R. K., & Jones, R. N. (2014). Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method. Antimicrob Agents Chemother.
Citação norma ChicagoMendes, Rodrigo E., David J. Farrell, Helio S. Sader, Robert K. Flamm, and Ronald N. Jones. "Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) As Determined By the Revised Susceptibility Testing Method." Antimicrob Agents Chemother 2014.
MLA citiranjeMendes, Rodrigo E., et al. "Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) As Determined By the Revised Susceptibility Testing Method." Antimicrob Agents Chemother 2014.